泰格医药(300347.SZ)发布前三季度业绩，归母净利润10.2亿元，增长25.45%

Core Viewpoint - Tiger Med (300347.SZ) reported a slight decrease in revenue for the first three quarters of 2025, while net profit showed significant growth year-on-year [1] Financial Performance - The company's revenue for the first three quarters was 5.026 billion yuan, a year-on-year decrease of 0.82% [1] - Net profit attributable to shareholders was 1.02 billion yuan, reflecting a year-on-year increase of 25.45% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 326 million yuan, a year-on-year decrease of 63.46% [1] - Basic earnings per share were 1.19 yuan [1]